Literature DB >> 10911382

Iron absorption and transport-an update.

M E Conrad1, J N Umbreit.   

Abstract

Iron is vital for all living organisms. However, excess iron is hazardous because it produces free radical formation. Therefore, iron absorption is carefully regulated to maintain an equilibrium between absorption and body loss of iron. In countries where heme is a significant part of the diet, most body iron is derived from dietary heme iron because heme binds few of the luminal intestinal iron chelators that inhibit absorption of non-heme iron. Uptake of luminal heme into enterocytes occurs as a metalloporphyrin. Intracellularly, iron is released from heme by heme oxygenase so that iron leaves the enterocyte to enter the plasma as non-heme iron. Ferric iron is absorbed via a beta(3) integrin and mobilferrin (IMP) pathway that is not shared with other nutritional metals. Ferrous iron uptake is facilitated by DMT-1 (Nramp-2, DCT-1) in a pathway shared with manganese. Other proteins were recently described which are believed to play a role in iron absorption. SFT (Stimulator of Iron Transport) is postulated to facilitate both ferric and ferrous iron uptake, and Hephaestin is thought to be important in transfer of iron from enterocytes into the plasma. The iron concentration within enterocytes reflects the total body iron and either upregulates or satiates iron-binding sites on regulatory proteins. Enterocytes of hemochromatotics are iron-depleted similarly to the absorptive cells of iron-deficient subjects. Iron depletion, hemolysis, and hypoxia each can stimulate iron absorption. In non-intestinal cells most iron uptake occurs via either the classical clathrin-coated pathway utilizing transferrin receptors or the poorly defined transferrin receptor independent pathway. Non-intestinal cells possess the IMP and DMT-1 pathways though their role in the absence of iron overload is unclear. This suggests that these pathways have intracellular functions in addition to facilitating iron uptake. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10911382     DOI: 10.1002/1096-8652(200008)64:4<287::aid-ajh9>3.0.co;2-l

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  40 in total

1.  Transepithelial heme-iron transport: effect of heme oxygenase overexpression.

Authors:  M J Mendiburo; S Le Blanc; A Espinoza; F Pizarro; M Arredondo
Journal:  Eur J Nutr       Date:  2010-11-16       Impact factor: 5.614

Review 2.  Ageing and the gut.

Authors:  A L D'Souza
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

3.  Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis.

Authors:  Lun-Hua Chen; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

4.  In vitro dissolution profile of two commercially available iron preparations.

Authors:  José P H Patrício; Cristina Santos; Rui Cerdeira
Journal:  Drugs R D       Date:  2012-03-01

Review 5.  Iron deficiency anemia in children.

Authors:  Girish Subramaniam; Meenakshi Girish
Journal:  Indian J Pediatr       Date:  2015-02-01       Impact factor: 1.967

6.  Changes in Hematology and Calcium Metabolism After Gastric Bypass Surgery--a 2-Year Follow-Up Study.

Authors:  Dorte Worm; Sten Madsbad; Viggo B Kristiansen; Lars Naver; Dorte Lindqvist Hansen
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

7.  Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.

Authors:  Jörn Karhausen; Glenn T Furuta; John E Tomaszewski; Randall S Johnson; Sean P Colgan; Volker H Haase
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Low brain iron effects and reversibility on striatal dopamine dynamics.

Authors:  Erica L Unger; Laura E Bianco; Byron C Jones; Richard P Allen; Christopher J Earley
Journal:  Exp Neurol       Date:  2014-07-03       Impact factor: 5.330

Review 9.  Trafficking of heme and porphyrins in metazoa.

Authors:  Scott Severance; Iqbal Hamza
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

10.  Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor.

Authors:  Jason Papademetriou; Carmen Garnacho; Daniel Serrano; Tridib Bhowmick; Edward H Schuchman; Silvia Muro
Journal:  J Inherit Metab Dis       Date:  2012-09-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.